title: Sequential IL-2 and IL-2R levels predict rejection in liver allograft recipients.
authors.affiliation: New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215.
authors.forename: M A
authors.initials: MA
authors.lastname: Simpson
authors.forename: T
authors.initials: T
authors.lastname: Young-Fadok
authors.forename: P N
authors.initials: PN
authors.lastname: Madras
authors.forename: R B
authors.initials: RB
authors.lastname: Freeman
authors.forename: R A
authors.initials: RA
authors.lastname: Dempsey
authors.forename: R L
authors.initials: RL
authors.lastname: Jenkins
authors.forename: A P
authors.initials: AP
authors.lastname: Monaco
mesh_terms: D001646:Bile / Q000378:metabolism; D003524:Cyclosporins / Q000009:adverse effects; D006084:Graft Rejection; D006801:Humans; D007376:Interleukin-2 / Q000097:blood / Q000378:metabolism* / Q000652:urine; D016031:Liver Transplantation / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000097:blood / Q000378:metabolism* / Q000652:urine
chemical_list: D003524:Cyclosporins; D007376:Interleukin-2; D015375:Receptors, Interleukin-2